Matulonis, U A: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Ovarian cancer

Matulonis, Ursula A., Sood, Anil K., Fallowfield, Lesley, Howitt, Brooke E., Sehouli, Jalid, Karlan, Beth Y.

Journal:

Nature Reviews Disease Primers

Year:

2016

Language:

english

File:

PDF, 6.15 MB

english, 2016

2

Initial safety and activity findings from a phase IB escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα-targeting antibody-drug conjugate (ADC), with pembrolizumab in platinum-resistant epithelial ovarian cancer (EOC) patients

Matulonis, U.A., Moore, K.N., Martin, L.P., Vergote, I.B., Castro, C.M., Gilbert, L., Berkenblit, A., Birrer, M.J., O'Malley, D.M.

Journal:

Gynecologic Oncology

Year:

2018

Language:

english

File:

PDF, 125 KB

english, 2018

3

Long-Term Adjustment of Survivors of Ovarian Cancer Treated for Advanced-Stage Disease

Kornblith, Alice B., Mirabeau-Beale, Kristina, Lee, Hang, Goodman, Anne Kathryn, Penson, Richard T., Pereira, Lauren, Matulonis, Ursula A.

Journal:

Journal of Psychosocial Oncology

Year:

2010

Language:

english

File:

PDF, 118 KB

english, 2010

4

Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas

Ritterhouse, Lauren L, Nowak, Jonathan A, Strickland, Kyle C, Garcia, Elizabeth P, Jia, Yonghui, Lindeman, Neal I, Macconaill, Laura E, Konstantinopoulos, Panagiotis A, Matulonis, Ursula A, Liu, Joyce

Journal:

Modern Pathology

Year:

2016

Language:

english

File:

PDF, 2.88 MB

english, 2016

5

A Phase II Study of the MDR Inhibitor Biricodar (INCEL, VX-710) and Paclitaxel in Women with Advanced Ovarian Cancer Refractory to Paclitaxel Therapy

Michael V. Seiden, Kenneth D. Swenerton, Ursula Matulonis, Susan Campos, Peter Rose, Gerald Batist, Ene Ette, Varun Garg, Arlan Fuller, Matthew W. Harding, Danielle Charpentier

Journal:

Gynecologic Oncology

Year:

2002

Language:

english

File:

PDF, 88 KB

english, 2002

6

A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer

Anna Berkenblit, Michael V. Seiden, Ursula A. Matulonis, Richard T. Penson, Carolyn N. Krasner, Maria Roche, Lisa Mezzetti, Tina Atkinson, Stephen A. Cannistra

Journal:

Gynecologic Oncology

Year:

2004

Language:

english

File:

PDF, 169 KB

english, 2004

7

The Feasibility and Effects of Acupuncture on Quality of Life Scores During Chemotherapy in Ovarian Cancer: Results from a Pilot, Randomized Sham-Controlled Trial

Lu, Weidong, Matulonis, Ursula A., Dunn, Julie E., Lee, Hang, Doherty-Gilman, Anne, Dean-Clower, Elizabeth, Goodman, Annekathryn, Davis, Roger B., Buring, Julie, Wayne, Peter, Rosenthal, David S., Pen

Journal:

Medical Acupuncture

Year:

2012

Language:

english

File:

PDF, 292 KB

english, 2012

8

Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy

Montero, Joan, Sarosiek, Kristopher A., DeAngelo, Joseph D., Maertens, Ophélia, Ryan, Jeremy, Ercan, Dalia, Piao, Huiying, Horowitz, Neil S., Berkowitz, Ross S., Matulonis, Ursula, Jänne, Pasi A., Amr

Journal:

Year:

2015

Language:

english

File:

PDF, 2.50 MB

english, 2015

9

Quality of Care and Outcomes in Patients With Diabetes Hospitalized With Ischemic Stroke: Findings From Get With the Guidelines-Stroke

Reeves, M. J., Vaidya, R. S., Fonarow, G. C., Liang, L., Smith, E. E., Matulonis, R., Olson, D. M., Schwamm, L. H.

Journal:

Year:

2010

Language:

english

File:

PDF, 413 KB

english, 2010

10

Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high grade serous ovarian and breast cancer

Matulonis, U.A., Wulf, G.M., Barry, W.T., Birrer, M., Westin, S.N., Farooq, S., Bell-McGuinn, K.M., Obermayer, E., Whalen, C., Spagnoletti, T., Luo, W., Liu, H., Hok, R.C., Aghajanian, C., Solit, D.B.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 428 KB

english, 2016

11

The poly (ADP ribose) polymerase inhibitor niraparib: Management of toxicities

Moore, Kathleen N., Mirza, Mansoor Raza, Matulonis, Ursula A.

Journal:

Gynecologic Oncology

Year:

2018

Language:

english

File:

PDF, 556 KB

english, 2018

12

A Phase I–II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent müllerian tumors

Richard T. Penson, Jeffrey G. Supko, Michael V. Seiden, Arlan F. Fuller, Ross S. Berkowitz, Annekathryn Goodman, Susana M. Campos, Kimberley M. MacNeill, Sarah Cook, Ursula A. Matulonis

Journal:

Year:

2001

Language:

english

File:

PDF, 129 KB

english, 2001

13

Autologous peripheral stem cell transplantation of the blastic phase of chronic myeloid leukemia following sequential high-dose cytosine arabinoside and melphalan

Ursula A. Matulonis, James D. Griffin, Dr. George P. Canellos

Journal:

American Journal of Hematology

Year:

1994

Language:

english

File:

PDF, 389 KB

english, 1994

14

Influence of patients' preferences and treatment site on cancer patients' end-of-life care

Alexi A. Wright, Jennifer W. Mack, Patricia A. Kritek, Tracy A. Balboni, Anthony F. Massaro, Ursula A. Matulonis, Susan D. Block, Holly G. Prigerson

Journal:

Year:

2010

Language:

english

File:

PDF, 166 KB

english, 2010

15

Inability to escalate vinorelbine dose intensity using a daily × 3 schedule with and without filgrastim in patients with metastatic breast cancer

Kathleen A. Havlin, Michael J. Ramirez, Christine M. Legler, Lydsay N. Harris, Ursula A. Matulonis, John A. Hohneker, Daniel F. Hayes, Eric P. Winer

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1999

Language:

english

File:

PDF, 140 KB

english, 1999

16

Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer

Susana M. Campos, Suzanne T. Berlin, Leroy M. Parker, Wendy Y. Chen, Craig A. Bunnell, Tina Atkinson, Julie Lee, Ursula Matulonis, Michelle S. Hirsch, Lyndsay Harris, Carolyn N. Krasner

Journal:

International Journal of Clinical Oncology

Year:

2010

Language:

english

File:

PDF, 277 KB

english, 2010

17

Anti-angiogenic Agents in Ovarian Cancer: Dawn of a New Era?

Joyce Liu, Ursula A. Matulonis

Journal:

Current Oncology Reports

Year:

2011

Language:

english

File:

PDF, 161 KB

english, 2011

18

A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors

R.T. PENSON, S.M. CAMPOS, M.V. SEIDEN, C. KRASNER, A.F. FULLER Jr, A. GOODMAN, M. ROCHE, A. WILLMAN, A. MUZIKANSKY, U.A. MATULONIS, Gynecologic Oncology Research Program at Dana Farber/Partners Cancer

Journal:

International Journal of Gynecological Cancer

Year:

2005

Language:

english

File:

PDF, 86 KB

english, 2005

19

Long-term adjustment of early-stage ovarian cancer survivors

U.A. MATULONIS, A. KORNBLITH, H. LEE, J. BRYAN, C. GIBSON, C. WELLS, J. LEE, L. SULLIVAN, R. PENSON

Journal:

International Journal of Gynecological Cancer

Year:

2008

Language:

english

File:

PDF, 117 KB

english, 2008

20

Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer

Kaye, S. B., Lubinski, J., Matulonis, U., Ang, J. E., Gourley, C., Karlan, B. Y., Amnon, A., Bell-McGuinn, K. M., Chen, L.-M., Friedlander, M.

Journal:

Journal of Clinical Oncology

Year:

2012

Language:

english

File:

PDF, 165 KB

english, 2012

21

Review: erythropoiesis-stimulating agents increase mortality in patients with cancer

Journal:

Evidence-Based Medicine

Year:

2009

Language:

english

File:

PDF, 170 KB

english, 2009

22

Phase I Trial of Carboplatin, Paclitaxel, Etoposide, and Cyclophosphamide with Granulocyte Colony Stimulating Factor as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer

Nadine Tung, Ross Berkowitz, Ursula Matulonis, Marc Quartulli, Michael Seiden, Young Kim, Jonathan Niloff, Stephen A. Cannistra

Journal:

Gynecologic Oncology

Year:

2000

Language:

english

File:

PDF, 56 KB

english, 2000

23

The Clinical Utility of Liposomal Doxorubicin in Recurrent Ovarian Cancer

Susana M. Campos, Richard T. Penson, Aisha R. Mays, Ross S. Berkowitz, Arlan F. Fuller, Annekathryn Goodman, Ursula A. Matulonis, Alona Muzikansky, Michael V. Seiden

Journal:

Gynecologic Oncology

Year:

2001

Language:

english

File:

PDF, 63 KB

english, 2001

24

Metaplastic carcinoma of the breast with neuroglial differentiation

Mehra Golshan, Adam Kuten, Jacquleine William, Andrea Richardson, Amir Modarressi, Ursula Matulonis

Journal:

Year:

2006

Language:

english

File:

PDF, 598 KB

english, 2006

25

Long-Acting Octreotide for the Treatment and Symptomatic Relief of Bowel Obstruction in Advanced Ovarian Cancer

Ursula A. Matulonis, Michael V. Seiden, Maria Roche, Carolyn Krasner, Arlan F. Fuller, Tina Atkinson, Alice Kornblith, Richard Penson

Journal:

Journal of Pain and Symptom Management

Year:

2005

Language:

english

File:

PDF, 89 KB

english, 2005

26

Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies

Richard T Penson, Michael V Seiden, Annekathryn Goodman, Arlan F Fuller Jr., Ross S Berkowitz, Ursula A Matulonis, Carolyn Krasner, Hang Lee, Tina Atkinson, Susana M Campos

Journal:

Gynecologic Oncology

Year:

2004

Language:

english

File:

PDF, 123 KB

english, 2004

27

A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer

Michael V Seiden, Franco Muggia, Allan Astrow, Ursula Matulonis, Susanna Campos, Maria Roche, Julia Sivret, Jason Rusk, Emma Barrett

Journal:

Gynecologic Oncology

Year:

2004

Language:

english

File:

PDF, 95 KB

english, 2004

28

Attitudes to chemotherapy in patients with ovarian cancer

R.T. Penson, F. Dignan, M.V. Seiden, H. Lee, C.J. Gallagher, U.A. Matulonis, K. Olson, I. Gibbens, M.E. Gore

Journal:

Gynecologic Oncology

Year:

2004

Language:

english

File:

PDF, 398 KB

english, 2004

29

Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions

Chyh-Woei Lee, Ursula A. Matulonis, Mariana C. Castells

Journal:

Gynecologic Oncology

Year:

2004

Language:

english

File:

PDF, 107 KB

english, 2004

30

A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with “high-risk” endometrial cancer

Linda R. Duska, Ross Berkowitz, Ursula Matulonis, Michael Muto, Annekathryn Goodman, James F. Mcintyre, Amber Klein, Tina Atkinson, Michael V. Seiden, Susana Campos

Journal:

Gynecologic Oncology

Year:

2005

Language:

english

File:

PDF, 356 KB

english, 2005

31

Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments

Anna M. Feldweg, Chyh-Woei Lee, Ursula A. Matulonis, Mariana Castells

Journal:

Gynecologic Oncology

Year:

2005

Language:

english

File:

PDF, 94 KB

english, 2005

32

Å6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: A phase I trial

Anna Berkenblit, Ursula A. Matulonis, Joan F. Kroener, Bruce J. Dezube, Gil N. Lam, Luceli C. Cuasay, Nils Brünner, Terence R. Jones, Michael H. Silverman, Michael A. Gold

Journal:

Gynecologic Oncology

Year:

2005

Language:

english

File:

PDF, 330 KB

english, 2005

33

Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: Standard protocol effective in 57 patients for 255 courses

Chyh-Woei Lee, Ursula A. Matulonis, Mariana C. Castells

Journal:

Gynecologic Oncology

Year:

2005

Language:

english

File:

PDF, 103 KB

english, 2005

34

A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer

Michael V. Seiden, Alan N. Gordon, Diane C. Bodurka, Ursula A. Matulonis, Richard T. Penson, Eddie Reed, Dave S. Alberts, Garry Weems, Michael Cullen, William P. McGuire III

Journal:

Gynecologic Oncology

Year:

2006

Language:

english

File:

PDF, 112 KB

english, 2006

35

Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer

U.A. Matulonis, S. Campos, L. Duska, C.N. Krasner, T. Atkinson, R.T. Penson, M.V. Seiden, C. Verrill, A.F. Fuller, A. Goodman

Journal:

Gynecologic Oncology

Year:

2006

Language:

english

File:

PDF, 127 KB

english, 2006

36

Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: The modified triple doublet regimen

U.A. Matulonis, S. Campos, C.N. Krasner, L.R. Duska, R.T. Penson, R. Falke, M. Roche, L.M. Smith, H. Lee, M.V. Seiden

Journal:

Gynecologic Oncology

Year:

2006

Language:

english

File:

PDF, 174 KB

english, 2006

37

Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma

Ramey D. Littell, Heidi Hallonquist, Ursula Matulonis, Michael V. Seiden, Ross S. Berkowitz, Linda R. Duska

Journal:

Gynecologic Oncology

Year:

2006

Language:

english

File:

PDF, 121 KB

english, 2006

38

A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies

M.V. Seiden, H.A. Burris, U. Matulonis, J.B. Hall, D.K. Armstrong, J. Speyer, J.D.A. Weber, F. Muggia

Journal:

Gynecologic Oncology

Year:

2007

Language:

english

File:

PDF, 174 KB

english, 2007

39

Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors

Ursula A. Matulonis, Karen J. Krag, Carolyn N. Krasner, Tina Atkinson, Neil S. Horowitz, Hang Lee, Richard T. Penson

Journal:

Gynecologic Oncology

Year:

2009

Language:

english

File:

PDF, 240 KB

english, 2009

40

Comparison of the quality of life of early and advanced stage ovarian cancer survivors

Kristina L. Mirabeau-Beale, Alice B. Kornblith, Richard T. Penson, Hang Lee, Annekathryn Goodman, Susana M. Campos, Linda Duska, Lauren Pereira, Jessica Bryan, Ursula A. Matulonis

Journal:

Gynecologic Oncology

Year:

2009

Language:

english

File:

PDF, 175 KB

english, 2009

41

Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma

Joyce F. Liu, Michelle S. Hirsch, Hang Lee, Ursula A. Matulonis

Journal:

Gynecologic Oncology

Year:

2009

Language:

english

File:

PDF, 813 KB

english, 2009

42

Phase II trial of GM-CSF in women with asymptomatic recurrent müllerian tumors

Maria R. Roche, Pandora J. Rudd, Carolyn N. Krasner, Ursula A. Matulonis, Suzanne T. Berlin, Hang Lee, Michael Silver, Chau D. Tran, Michael V. Seiden, Richard T. Penson

Journal:

Gynecologic Oncology

Year:

2010

Language:

english

File:

PDF, 268 KB

english, 2010

43

CA-125 changes can predict optimal interval cytoreduction in patients with advanced-stage epithelial ovarian cancer treated with neoadjuvant chemotherapy

N. Rodriguez, J. Rauh-Hain, C. Feltmate, M. Del Carmen, R. Penson, A. Goodman, U. Matulonis, M. Muto, J. Schorge, N. Horowitz

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 108 KB

english, 2011

44

STAC: A phase II study of carboplatin/paclitaxel/bevacizumab followed by randomization to either bevacizumab alone or erlotinib and bevacizumab in the upfront management of patients with ovarian, fallopian tube or peritoneal cancer

S. Campos, T. Atkinson, S. Berlin, M. Roche, C. Whalen, U. Matulonis, N. Horowitz, M. Birrer, R. Penson

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 48 KB

english, 2011

45

Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels

Christine M. Coticchia, Adam S. Curatolo, David Zurakowski, Jiang Yang, Kathryn E. Daniels, Ursula A. Matulonis, Marsha A. Moses

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 423 KB

english, 2011

46

The importance of chemotherapy and radiation in uterine papillary serous carcinoma

Akila N. Viswanathan, Eric A. Macklin, Ross Berkowitz, Ursula Matulonis

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 328 KB

english, 2011

47

Bevacizumab rechallenge after first line maintenance bevacizumab

Panagiotis A. Konstantinopoulos, Suzanne T. Berlin, Susana M. Campos, Ursula A. Matulonis, Stephen A. Cannistra

Journal:

Gynecologic Oncology

Year:

2012

Language:

english

File:

PDF, 63 KB

english, 2012

48

Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy

Noah Rodriguez, J. Alejandro Rauh-Hain, Melina Shoni, Ross S. Berkowitz, Michael G. Muto, Colleen Feltmate, John O. Schorge, Marcela G. del Carmen, Ursula A. Matulonis, Neil S. Horowitz

Journal:

Gynecologic Oncology

Year:

2012

Language:

english

File:

PDF, 335 KB

english, 2012

49

Sequential bevacizumab and oral cyclophosphamide for recurrent ovarian cancer

Ursula A. Matulonis, Lauren Pereira, Joyce Liu, Hang Lee, Julie Lee, Christin Whalen, Susana Campos, Tina Atkinson, Margaret Hill, Suzanne Berlin

Journal:

Gynecologic Oncology

Year:

2012

Language:

english

File:

PDF, 228 KB

english, 2012

50

Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors

Susanna M Campos, Ursula A Matulonis, Richard T Penson, Hang Lee, Ross S Berkowitz, Linda R Duska, Arlan F Fuller Jr., Kara S Wilson, Thomas A Puchalski, Jeffrey G Supko, Michael V Seiden

Journal:

Gynecologic Oncology

Year:

2003

Language:

english

File:

PDF, 244 KB

english, 2003